2011
Regulation of human osteoclast development by dendritic cell‐specific transmembrane protein (DC‐STAMP)
Chiu Y, Mensah KA, Schwarz EM, Ju Y, Takahata M, Feng C, McMahon LA, Hicks DG, Panepento B, Keng PC, Ritchlin CT. Regulation of human osteoclast development by dendritic cell‐specific transmembrane protein (DC‐STAMP). Journal Of Bone And Mineral Research 2011, 27: 79-92. PMID: 21987375, PMCID: PMC3304467, DOI: 10.1002/jbmr.531.Peer-Reviewed Original ResearchConceptsDendritic cell-specific transmembrane proteinImmunoreceptor tyrosine-based inhibitory motifOC precursorsInflammatory arthritisTransmembrane proteinSH2 domain-containing tyrosine phosphataseTransmembrane receptor-like proteinErosive inflammatory arthritisCell fusionTumor giant cellsMetabolic bone diseaseReceptor-like proteinDC-STAMP expressionTyrosine-based inhibitory motifCell surface receptorsBone diseaseHuman PBMCsTyrosine phosphataseOsteoclast developmentCytoplasmic tailGiant cellsCellular transformationOC formationOsteoclastogenesisSHP-1
2010
CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis
Chiu YG, Shao T, Feng C, Mensah KA, Thullen M, Schwarz EM, Ritchlin CT. CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Research & Therapy 2010, 12: r14. PMID: 20102624, PMCID: PMC2875642, DOI: 10.1186/ar2915.Peer-Reviewed Original ResearchConceptsCD16 expressionOC precursorsInflammatory arthritisHealthy controlsMethodsPeripheral blood mononuclear cellsNuclear factor kappa-B ligandCD16-positive monocytesSubset of CD14Chronic inflammatory arthritisBlood mononuclear cellsHuman peripheral bloodCD16 surface expressionColony-stimulating factorPsA patientsPsoriatic arthritisBone erosionDendritic cellsPsoriasis subjectsMononuclear cellsPeripheral bloodTumor necrosisCD16Receptor activatorBone wafersArthritis
2008
Altered bone remodeling in psoriatic arthritis
Mensah KA, Schwarz EM, Ritchlin CT. Altered bone remodeling in psoriatic arthritis. Current Rheumatology Reports 2008, 10: 311-317. PMID: 18662512, PMCID: PMC2656567, DOI: 10.1007/s11926-008-0050-5.Peer-Reviewed Original ResearchConceptsPsoriatic arthritisTumor necrosis factor inhibitionInflammatory joint diseaseNecrosis factor inhibitionBasic science findingsInflammatory arthritisNew bone formationBone resorptionFactor inhibitionJoint diseaseBone homeostasisArthritisBone formationAltered boneSkeletal systemBone biologyDynamic organClinical applicationPivotal roleRecent studiesBoneOsteoimmunologyScience findings